Skip to main content

A multi-center, open-label, uncontrolled, single-arm, extension study to determine the long-term safety and tolerability of oral lucerastat in adult subjects with Fabry disease

  • Protocol code: ID-069A302
  • EudraCT code: 2018-002210-12
  • Research group: Neurodegenerative Diseases
  • Service: Internal Medicine
  • Principal investigator:  Camprodon Gomez, Maria
  • Pathology: Malalties del sistema nerviós
  • Phase: Fase III
  • Status: Recruiting volunteers